I graduated with a Bachelor's degree from Shandong First Medical University and a Master's degree from Beijing University of Technology. During my master's program, my primary research focus was exploring the connection between redox homeostasis and ferroptosis in breast cancer cells. Since the establishment of CIMR last year, I have been closely following its progress. In January 2024, I enrolled in CIMR's Winter School program. Over the course of seven days, I attended lectures by esteemed medical scientists and physician-scientists who shared their research achievements and life experiences, gaining a deep understanding of CIMR's educational philosophy and graduate training system. In September, I officially became a member of CIMR and embarked on the laboratory rotation phase.

After two months of rotation, I have found CIMR to be a dynamic and innovative research institute, boasting a domestically top-tier team of Principal Investigators (PIs), ample research funding, advanced platform facilities, and abundant academic resources. The research directions of the PIs all originate from clinical practical problems, aiming at the clinical translation of research achievements and ultimately alleviating and eliminating patient suffering. As a graduate student, under the guidance of the PIs, I have access to the forefront of research topics, can expand my research direction based on my interests, and receive professional scientific training.

Currently, my research interest primarily lies in exploring the molecular mechanisms underlying the regulation of ferroptosis by phospholipid metabolism in tumor cells, with the hope of developing novel therapeutic strategies targeting phospholipid metabolism and ferroptosis for tumor treatment in the future.